These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 22278202

  • 1. Central venous line dysfunction is an independent predictor of poor survival in children with cancer.
    Athale UH, Siciliano S, Cheng J, Thabane L, Chan AK.
    J Pediatr Hematol Oncol; 2012 Apr; 34(3):188-93. PubMed ID: 22278202
    [Abstract] [Full Text] [Related]

  • 2. Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer.
    Athale U, Siciliano S, Thabane L, Pai N, Cox S, Lathia A, Khan A, Armstrong A, Chan AK.
    Pediatr Blood Cancer; 2008 Dec; 51(6):792-7. PubMed ID: 18798556
    [Abstract] [Full Text] [Related]

  • 3. Do children with central venous line (CVL) dysfunction have increased risk of symptomatic thromboembolism compared to those without CVL-dysfunction, while on cancer therapy?
    Halton J, Nagel K, Brandão LR, Silva M, Gibson P, Chan A, Blyth K, Hicks K, Parmar N, Paddock L, Willing S, Thabane L, Athale U.
    BMC Cancer; 2012 Jul 26; 12():314. PubMed ID: 22835078
    [Abstract] [Full Text] [Related]

  • 4. Thromboembolism in children with sarcoma.
    Athale U, Cox S, Siciliano S, Chan AK.
    Pediatr Blood Cancer; 2007 Aug 26; 49(2):171-6. PubMed ID: 16991135
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Incidence and risk factors for venous thromboembolism in critically ill children after trauma.
    Hanson SJ, Punzalan RC, Greenup RA, Liu H, Sato TT, Havens PL.
    J Trauma; 2010 Jan 26; 68(1):52-6. PubMed ID: 20065757
    [Abstract] [Full Text] [Related]

  • 7. Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies--a randomized, controlled study.
    Ruud E, Holmstrøm H, De Lange C, Hogstad EM, Wesenberg F.
    Acta Paediatr; 2006 Sep 26; 95(9):1053-9. PubMed ID: 16938749
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Risk factors for venous thromboembolism in children.
    Gerotziafas GT.
    Int Angiol; 2004 Sep 26; 23(3):195-205. PubMed ID: 15765033
    [Abstract] [Full Text] [Related]

  • 10. Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL.
    Ortega JJ, Ribera JM, Oriol A, Bastida P, González ME, Calvo C, Egurbide I, Hernández Rivas JM, Rivas C, Alcalá A, Besalduch J, Maciá J, Gardella S, Carnero M, Lite JM, Casanova F, Martinez M, Fontanillas M, Feliu E, San Miguel JF, PETHEMA Group, Spanish Society of Hematology. Programa para el Estudio y Tratamiento de las Hemopatías Malignas.
    Haematologica; 2001 Jun 26; 86(6):586-95. PubMed ID: 11418367
    [Abstract] [Full Text] [Related]

  • 11. Survival after relapse in children with solid tumors: a follow-up study from the Italian off-therapy registry.
    Ceschel S, Casotto V, Valsecchi MG, Tamaro P, Jankovic M, Hanau G, Fossati F, Pillon M, Rondelli R, Sandri A, Silvestri D, Haupt R, Cuttini M.
    Pediatr Blood Cancer; 2006 Oct 15; 47(5):560-6. PubMed ID: 16395684
    [Abstract] [Full Text] [Related]

  • 12. Central venous line thrombosis in children and young adults with thalassemia major.
    Finkelstein Y, Yaniv I, Berant M, Zilber R, Garty BZ, Epstein O, Lahav J, Tamary H.
    Pediatr Hematol Oncol; 2004 Oct 15; 21(5):375-81. PubMed ID: 15205080
    [Abstract] [Full Text] [Related]

  • 13. Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism.
    Parpia S, Julian JA, Thabane L, Lee AY, Rickles FR, Levine MN.
    Contemp Clin Trials; 2011 Nov 15; 32(6):829-33. PubMed ID: 21777700
    [Abstract] [Full Text] [Related]

  • 14. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
    Calaminus G, Bamberg M, Jürgens H, Kortmann RD, Sörensen N, Wiestler OD, Göbel U.
    Klin Padiatr; 2004 Nov 15; 216(3):141-9. PubMed ID: 15175958
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM, Ortega JJ, Oriol A, Granada I, Hernández-Rivas JM, Parody R, Bethencourt C, Rivas C, Bastida P, del Potro E, González-Valentín ME, Moreno MJ, Besalduch J, Fernández-Calvo J, Tormo M, Arias J, Molinés A, Sanz MA, Maldonado J, Millá F, Feliu E, San Miguel JF, PETHEMA Group, Spanish Society of Hematology.
    Haematologica; 2002 Feb 15; 87(2):154-66. PubMed ID: 11836166
    [Abstract] [Full Text] [Related]

  • 16. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH, Wang SS, Huang Y, Wang B, Huang HQ, Zhang L, Sun XF, Xu RH, Lin TY.
    Ai Zheng; 2006 Aug 15; 25(8):1013-8. PubMed ID: 16965685
    [Abstract] [Full Text] [Related]

  • 17. Thromboembolic complications in pediatric hematologic malignancies.
    Athale UH, Chan AK.
    Semin Thromb Hemost; 2007 Jun 15; 33(4):416-26. PubMed ID: 17525899
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.
    Aksentijevich I, Jones RJ, Ambinder RF, Garrett-Mayer E, Flinn IW.
    Biol Blood Marrow Transplant; 2006 Sep 15; 12(9):965-72. PubMed ID: 16920563
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.